Global EPharmacy Market By Drug Overview
E-Pharmacy Market was valued at US$ 85 billion in 2024 and is projected to grow at a CAGR of 21.0% to reach US$ 574 billion by 2034.
E-Pharmacy is web-based supplier of medicine which offers various benefits over premise-based retail pharmacy store. E-pharmacy platform provides all types of pharmaceutical drugs such as prescription products, OTC drugs, and personal care products to its customers. Where the customers just need to upload the prescription on the internet and the drugs are delivered at the doorstep of the customer.
For More Report Details, Download Free Sample PDF
Global EPharmacy Market By Drug Drivers & Restraints
The significant factor to drive the growth of the E-Pharmacy market is increasing penetration of internet and smart phones across the world. Due to which the consumers are shifting towards online based stores in almost all commodity. Further, ease in connectivity, consumers can demand the medicines without visiting any physical location, and can receive medicines and other articles in quickest time. In addition they could get counselling service and other important medical information about product they wish to order over phone.
Further, global increase in the geriatric population pool is steadily increasing. According to report by United Nation in 2017, global population above 60 is increasing at rate of 3% each year; it would reach 1.3Bn by 2025. However, aging population living alone often find it difficult to timely visit the retail pharmacy, and they also fail to memorize order due to age related dementia, Online pharmacy could provide solution to this with automated reminder about medicines order and other information.
However easy availability of drug through E-Pharmacy channel has led to incidence of adverse drug reaction due to analgesics, anxiolytics, anti-psychotics, opioids, and cough syrup etc. Therefore, most of national government are being cautious before granting rights to E-Pharmacy and strictly regulating the business which may lead to deterrence to market growth of the E-Pharmacy market.
Global EPharmacy Market By Drug Segmentations & Regional Insights
The E-Pharmacy market has been segmented on the basis of drug class and region.
On the basis of drug class the E-pharmacy market has been segmented into OTC drugs and prescription drugs.
Regional Insights:
Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.
E-Pharmacy Market Regional Insights
On the basis of region, the target market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to account major market share as compared to that of other regions.
Report scope:
Attribute |
Details |
Market Size 2024 |
US$ 85.0 Billion |
Projected Market Size 2034 |
US$ 574.0 Billion |
CAGR Growth Rate |
21.0% |
Base year for estimation |
2023 |
Forecast period |
2024 – 2034 |
Market representation |
Revenue in USD Million & CAGR from 2024 to 2034 |
Market Segmentation |
By Drug Class - OTC Drugs, and Prescription Drugs |
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered in the Report:
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2024 to 2034. For the purpose of this study, has segmented the E-Pharmacy Market report based on drug class and region:
E-Pharmacy Market, By Drug Class
- OTC Drugs
- Prescription Drugs
E-Pharmacy Market, By Region:
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
Global EPharmacy Market By Drug Competitive Landscape & Key Players
Key players operating in the E-Pharmacy Market include The Kroger Co., Walgreen Co., Wal-Mart Stores, Inc., CVS Health,Express Scripts Holding Company, Giant Eagle, Inc., DocMorris Rowlands Pharmacy, and OptumRx, Inc.
Global EPharmacy Market By Drug Recent News
Recent Development:
- In November 2023, Vice President of Ghana, Dr Mahamudu Bawumia officially launched the National Electronic Pharmacy Platform (NEPP). The NEPP is the first national-scale e-Pharmacy platform in Africa, and one of the few in the world. It is a digital convergence of licensed pharmacies across the country, which enables Ghanaians to have access to prescribed medicines and buy them by making an order with a mobile phone through the e-Pharmacy app, website, or a shortcode, and have the medicine delivered to a requested location.
Global EPharmacy Market By Drug Company Profile
- The Kroger Co.*
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Walgreen Co.
- Wal-Mart Stores, Inc.
- CVS Health
- Express Scripts Holding Company
- Giant Eagle, Inc.
- DocMorris Rowlands Pharmacy
- OptumRx, Inc.
“*” marked represents similar segmentation in other categories in the respective section
FAQs
E-Pharmacy Market is segmented, By Drug Class (OTC Drugs, and Prescription Drugs).
The significant factor to drive the growth of the E-Pharmacy market is increasing penetration of internet and smart phones across the world.
Key players operating in the E-Pharamacy market include The Kroger Co., Walgreen Co., Wal-Mart Stores, Inc., CVS Health,Express Scripts Holding Company, Giant Eagle, Inc., DocMorris Rowlands Pharmacy, and OptumRx, Inc.